Medikaloka Hermina Tbk PT
IDX:HEAL

Watchlist Manager
Medikaloka Hermina Tbk PT Logo
Medikaloka Hermina Tbk PT
IDX:HEAL
Watchlist
Price: 850 IDR 6.25% Market Closed
Market Cap: Rp13.1T

Wall St Price Targets

HEAL Price Targets Summary
Medikaloka Hermina Tbk PT

Wall Street analysts forecast HEAL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HEAL is 1 645.45 IDR with a low forecast of 1 161.5 IDR and a high forecast of 2 047.5 IDR.

Lowest Forecast
Price Target
1 161.5 IDR
37% Upside
Average Forecast
Price Target
1 645.45 IDR
94% Upside
Highest Forecast
Price Target
2 047.5 IDR
141% Upside
Medikaloka Hermina Tbk PT Competitors:
Price Targets

Revenue
Forecast

14% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
14% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 9 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 3 years is 10%.

Gross Profit
Forecast

10% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
10% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Medikaloka Hermina Tbk PT

Operating Income
Forecast

13% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
13% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 9 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 2 years is 19%.

Pre-Tax Income
Forecast

12% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
12% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Medikaloka Hermina Tbk PT

Net Income
Forecast

24% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss
24% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss

Over the last 9 years, the compound annual growth rate for Net Income has been 24%. The projected CAGR for the next 3 years is 12%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is HEAL's stock price target?
Price Target
1 645.45 IDR

According to Wall Street analysts, the average 1-year price target for HEAL is 1 645.45 IDR with a low forecast of 1 161.5 IDR and a high forecast of 2 047.5 IDR.

What is the Revenue forecast for Medikaloka Hermina Tbk PT?
Projected CAGR
10%

Over the last 9 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 3 years is 10%.

What is the Operating Income forecast for Medikaloka Hermina Tbk PT?
Projected CAGR
19%

Over the last 9 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 2 years is 19%.

What is the Net Income forecast for Medikaloka Hermina Tbk PT?
Projected CAGR
12%

Over the last 9 years, the compound annual growth rate for Net Income has been 24%. The projected CAGR for the next 3 years is 12%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett